Truncation of the amino terminus of PTH alters its anabolic activity on bone in vivo

Bone

Volumn 19, Issue 5 SUPPL., 1996, Pages 469-477

  Hilliker, S ^a,b   Wergedal, J E ^a,b   Gruber, H E ^c   Bettica, P ^a,b   Baylink, D J ^a,b  

^a Jerry L Pettis Memorial VA Medical Center   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CAROLINAS MEDICAL CENTER   (United States)

Author keywords

Bone formation; Bone resorption; INS PTH; Osteoporosis; PTH analog

Indexed keywords

ADENYLATE CYCLASE; ANABOLIC AGENT; BIOCHEMICAL MARKER; MITOGENIC AGENT; OSTEOCALCIN; PARATHYROID HORMONE; PROTEIN KINASE C;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CLEARANCE; ENZYME ACTIVATION; FEMALE; HORMONE STRUCTURE; MITOGENESIS; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PROTEIN DOMAIN; RAT; STRUCTURE ACTIVITY RELATION; SUBCUTANEOUS DRUG ADMINISTRATION; TRABECULAR BONE;

ANALYSIS OF VARIANCE; ANIMALS; BIOLOGICAL MARKERS; BODY WEIGHT; BONE DENSITY; BONE DEVELOPMENT; BONE RESORPTION; CELL DIFFERENTIATION; ENZYME ACTIVATION; FEMALE; HUMANS; MITOGENS; OSTEOBLASTS; OSTEOCALCIN; PARATHYROID HORMONE; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; TUMOR CELLS, CULTURED;

EID: 0029855956     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(96)00230-X     Document Type: Article

References (44)

1. Farley, J. R. and Baylink, D. J. Skeletal alkaline phosphatase as a bone formation index in vitro. Metabolism 35:563-571; 1986.
2. Parley, J. R., Hall, S. L., Herring, S., Tarbaux, N. M., Matsuyama, T., and Wergedal, J. E. Skeletal alkaline phosphatase specific activity is an index of the osteoblastic phenotype in subpopulations of the human osteosarcoma cell line SaOS-2. Metabolism 40:664-671; 1991.
3. Finch, J. L., Rapp, N., Martin, K. J., and Slatopolsky, E. A new sensitive homologous radioimmunoassay for amino-terminal parathyroid hormone in the rat. J Bone Miner Res 7:229-233; 1992.
4. Finkelman, R. D., Mohan, S., Linkhart, T. A., Abraham, S. M., Boussy, J. P., and Baylink, D. J. PTH stimulates the proliferation of TE-85 human osteosarcoma cells by a mechanism not involving either increased cAMP or increased secretion of IGF-1, IGF-II, or TGF-β. Bone Miner 16:89-100; 1992.
5. Fujimori, A., Cheng, S.-L., Avioli, L. V., and Civitelli, R. Dissociation of second messengers activation by parathyroid hormone fragments in osteosarcoma cells. Endocrinology 128:3032-3039; 1991.
6. Fujimori, A., Cheng, S.-L., Avioli, L.V., and Civitelli, R. Structure-function relationship of parathyroid hormone: Activation of phospholipase-C, protein kinase-A and -C in osteosarcoma cells. Endocrinology 130:29-36; 1992.
7. Gasser, J. A. amd Jerome, C. P. Parathyroid hormone: A cure for osteoporosis. Triangle 31:111-121; 1992.
8. Gruber, H. E., Marshall, G. J., Nolasco, L. M., Kirchen, M. E., and Rimoin. D. L. Alkaline and acid phosphatase demonstration in human bone and cartilage: Effects of fixation intervals and methacrylate embedments. Stain Technol 63:299-306; 1988.
9. Gruber, H. E. Adaptations of Goldner's-Masson trichrome stain for the study of undecalcified plastic-embedded bone. Biotech Histochem 67:30-34; 1992.
10. Gundberg, C. M., Hauschka, P. V., Lian, J. B., and Gallop, P. M. Osteocalcin: Isolation, characterization, and detection. Methods Enzymol 107:516-544; 1984.
11. Gunness-Hey, M. and Hock, J. M. Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone. Metab Dis Relat Res 5:177-181; 1984.
12. Gunness-Hey, M. and Hock, J. M. Loss of the anabolic effect of parathyroid hormone on bone after discontinuation of hormone in rats. Bone 10:447-452; 1989.
13. Herrmann-Erlee, M. P. M., van der Meer, J. M., Lowik, C. W. G. M., van Leeuwen, J. P. T. M., and Boonekamp, P. M. Different roles for calcium and cyclic AMP in the action of PTH: Studies in bone explants and isolated bone cells. Bone 9:93-100; 1988.
14. Hesch, R. D., Busch, U., Prokop, M., Delling, G., and Rittinghaus, E.-F. Increase of vertebral density by combination therapy with pulsatile l-38h1TH and sequential addition of calcitonin nasal spray in osteoporotic patients. Calcif Tissue Int 44:176-180; 1989.
15. Hesch, R. D., Heck, J., Delling, G., Keck, E., Reeve, J., Canzler, H., Schober. O., Harms, H., and Rittinghaus, E. F. Results of a stimulatory therapy of low bone metabolism in osteoporosis with (1-38)hPTH and diphosphonate EHDP. Klin Wonchenschr 66:976-984; 1988.
16. Hock, J. M., Fonseca, J., Gunness-Hey, M., Kemp, B. E., and Martin, T. J. Comparison of the anabolic effects of synthetic parathyroid hormone-related protein(PTHrP)l-34 and PTH 1-34 on bone in rats. Endocrinology 125:2022-2027; 1989.
17. Hock, J. M. and Gera, I. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone parathyroid hormone. J Bone Miner Res 7:65-72; 1992.
18. Hodsman, A. B., Fraher, L. J., Ostbye, T., Adachi, J. D., and Steer, B. M. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis. J Clin Invest 91:1138-1148; 1993.
19. Hodsman, A. B. and Fraher, L. J. Biochemical responses to sequential human parathyroid hormone (1-38) and calcitonin in osteoporotic patients. Bone Miner 9:137-152; 1990.
20. Jouishomme, H., Whitfield, J. F., Chakravarthy, B., Durkin, J. P., Gagnon, L., Isaacs, R. J., MacLean, S., Neugebauer, W., Willick, G., and Rixon, R. H. The protein kinase-C activation domain of the parathyroid hormone. Endocrinology 130:53-60; 1992.
21. Kaji, H., Sugimoto, T., Kanatani, M., and Fukase, M. The activation of cAMP-dependent protein kinase is directly linked to the stimulation of bone resorption by parathyroid hormone. Biochem Biophys Res Commun 182:1356-1361; 1992.
22. Kalu, D. N., Liu, C.-C., Hardin, R. R., and Hollis, B. W. The aged rat model of ovarian hormone deficiency bone loss. Endocrinology 124:7-16; 1989.
23. Kronis, K. A., Maeda, H., Kimmel, D. B., Bozzato, R. P., Coble, T., Sindrey, D., and Recker, R. R. Effect of three PTH analogues on bone mass and turnover in OX rats (abstract]. J Bone Miner Res 8(suppl 1):658; 1993.
24. Lau, K.-H. W., Onishi, T., Wergedal, J. E., Singer, F. R., and Baylink, D. J. Characterization and assay of tartrate-resistant acid phosphatase activity in serum: Potential use to assess bone resorption. Clin Chem 33:458-462; 1987.
25. Lerner, U. H., Ransjo, M., Ljungren, O., Klaushofer, K., Hoffmann, O., and Peterlik, M. On the role of cyclic AMP as a mediator of bone resorption: γ-interferon completely inhibits cholera toxin- and forskolin-induced but only partially inhibits parathyroid hormone-stimulated 45Ca release from mouse calvarial bones. J Bone Miner Res 6:551-560; 1991.
26. Liu, C.-C. and Kalu, D. N. Human parathyroid hormone (1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats. J Bone Miner Res 5:973-982; 1990.
27. Majeska, R. J., Rodan, S. B., and Rodan, G. A. Parathyroid hormone-responsive clonal cell lines from rat osteosarcoma. Endocrinology 107:1494-1503; 1980.
28. McCarthy, T. L., Centrella, M., and Canalis, E. Cyclic AMP induces insulin-like growth factor 1 synthesis in osteoblast-enriched cultures. J Biol Chem 265:15353-15356; 1990.
29. McGowan, J. A., Chen, T. C., Fragola, J., Puschett, J. B., and Rosenblatt, M. Parathyroid hormone: Effects of the 3-34 fragment in vivo and in vitro. Science 219:67-69; 1983.
30. Mohan, S. and Baylink, D. J. Evidence that the inhibition of TE85 human bone cell proliferation by agents which stimulate cAMP production may in part be mediated by changes in the IGF-II regulatory system. Growth Regul 1:110-118; 1991.
31. Parfitt, A. M. Bone histomorphometry: standardization of nomenclature, symbols and units. Summary of a proposed system. Bone Miner 4:1-5; 1988.
32. Potts, J. T. Jr., Segre, G. V., and Endres, D. B. Current clinical concepts: Assessment of parathyroid function with an N-terminal specific radioimmunoassay for intact parathyroid hormone. Nichols Institute Reference Laboratories; 1983.
33. Puzas, J. E., Drivdahl, R. H., Howard, G. A., and Baylink, D. J. Endogenous inhibitor of bone cell proliferation. Proc Soc Exp Biol Med 166:113-12; 1981.
34. Reeve, J., Bradbeer, J. N., Arlot, M., Davies, U. M., Green, J. R., Hampton, L., Edouard, C., Hesp, R., Hulme, P., Ashby, J. P., Zanelli, J. M., and Meunier, P. J. hPTH 1-34 treatment of osteoporosis with added hormone replacement therapy: Biochemical, kinetic and histological responses. Osteopor Int 1:162-170; 1991.
35. Reeve, J., Meunier, P. J., Parsons, J. A., Bemal, M., Bijvoet, O. L. M., Courpron. P., Edouard, C., Klenerman, L., Neer, R. M., Renier, J. C., Slovik, D., Vismans, F. J. F. E., and Potts, J. T. Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. Br Med J 280:1340-1344; 1980.
36. Rixon, R. H., Whitfield, J. F., Gagnon, L., Isaacs, R. J., MacClean, S., Chakravarthy, B., Durkin, J. P., Neugebauer, W., Ross, V., Sung, W., and Willick. G. E. Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase. J Bone Miner Res 9:1179-89; 1994.
37. Sabatini, M., Lesur, C., Pacherie, M., Pastoureau, P., Kucharczyk, N., Fauchere. J.-L., and Bonnet, J. Effects of parathyroid hormone and agonists of the adenylyl cyclase and protein krnase C pathways on bone cell proliferation. Bone 18:59-65; 1996.
38. Schluter, K.-D., Hellstern, H., Wingender, E., and Mayer, H. The central part of parathyroid hormone stimulates thymidine incorporation of chondrocytes. J Biol Chem 264:11087-11092; 1989.
39. Schultz, V. L., Boass, A., Toverud, S. U., and Garner, S. C. Elevated serum parathyroid hormone concentrations in rats under pentobarbital or methoxyflurane but not under ether or ketamine anesthesia. J Bone Miner Res 9 (Suppl 1):S408; 1994.
40. Segre, G. V., Rosenblatt, M., and Tully G. L. III, Laugharn, J., Reit, B., and Potts, J. T., Jr. Evaluation of an in vitro parathyroid hormone antagonist in vivo in dogs. Endocrinology 116:1024-1029; 1985.
41. Slovik, D. M., Neer, R. M., and Potts, J. T., Jr. Short-term effects of synthetic human parathyroid hormone-(1-34) administration on bone mineral metabolism in osteoporotic patients. J Clin Invest 68:1261-1271; 1981.
42. Somjen, D., Binderman, I., Schluter, K.-D., Wingender, E., Mayer, H., and Kaye, A. M. Stimulation by defined parathyroid hormone fragments of cell proliferation in skeletal-derived cell cultures. Biochem J 272:781-785; 1990.0
43. Tregear, G. W., Rietschoten, J. V., Greene, E., Keutmann, H. T., Niall, H. D., Reit, B., Parsons, J. A., and Potts, J. T., Jr. Bovine parathyroid hormone: mini-mum chain length of synthetic peptide required for biological activity. Endocrinology 93:1349-1353; 1973.
44. Wronski, T. J., Yen, C.-F., Qi, H., and Dann, L. M. Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats. Endocrinology 132:823-831; 1993.